Stay updated on Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial
Sign up to get notified when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.

Latest updates to the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision history now includes a new entry for v3.6.3 and excludes the previous v3.6.2 entry, updating the latest version listed in the study record history.SummaryDifference0.1%

- Check23 days agoChange DetectedThe Revision label on the Record History page now shows v3.6.2 instead of v3.6.0, indicating a newer build of the page. The update updates the page's version indicator without changing the study details or history entries.SummaryDifference0.1%

- Check38 days agoChange DetectedThe Study Record Versions area now shows additional metadata labels—Last verified and Last known status was—and includes a new revision marker (Revision: v3.6.0), indicating an updated page version and verification metadata.SummaryDifference3%

- Check45 days agoChange DetectedA new Revision label, v3.5.5, replaces the previous v3.5.4, indicating a new build of the page; this update reflects an internal version change rather than alterations to trial information.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision label (Revision: v3.5.4) was added to the record history, and the previous label (Revision: v3.5.3) was removed.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision history shows a new page version, from v3.5.2 to v3.5.3, indicating a minor update to the record's metadata.SummaryDifference0.1%

Stay in the know with updates to Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of HBM4003 + Toripalimab in Antitumor Clinical Trial page.